US Patent Issued to GENMAB on July 8 for "Antibodies binding to fibroblast activation protein alpha and death receptor 4" (Dutch Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,650, issued on July 8, was assigned to GENMAB A/S (Valby, Denmark).

"Antibodies binding to fibroblast activation protein alpha and death receptor 4" was invented by Bart E.C.G. De Goeij (Maarssen, Netherlands), Ilse Jongerius (De Bilt, Netherlands), Grietje Andringa (Utrecht, Netherlands), Madelon Paauwe (The Hague, Netherlands), Theodorus Sjouke Plantinga (Duiven, Netherlands), David Satijn (Nieuwegein, Netherlands), Jamila Laoukili (Zeist, Netherlands), Onno Wouter Kranenburg (Zeist, Netherlands) and Marije Overdijk (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a multispecific antibody compris...